Sydney Reporting System for Lymph Node Fine-Needle Aspiration and Malignancy Risk Stratification: Is It of Clinical Value?
Open Access
- 17 August 2024
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 14 (16) , 1801
Abstract
Lymphadenopathy is a common presentation of both reactive and malignant diseases, and lymph node fine-needle aspiration cytology (LN-FNAC) is an effective and inexpensive screening method. It can prevent unnecessary invasive surgery and excisional biopsy, especially in benign cases. Unfortunately, the lack of universally accepted terminology for reporting results has hindered its widespread support. The Sydney system proposal for lymph node cytopathology categorization and reporting introduced five diagnostic categories to address the lack of universally accepted terminology for reporting results in lymphadenopathy. Our study analyzed 188 lymph node fine-needle cytology (FNC) samples from King Abdulaziz University Hospital, Saudi Arabia, examining clinical follow-up data, pathology records, patient information, and final diagnosis from January 2019 to December 2022. Most specimens were from axillary lymph nodes, with 99.5% tissue correlation. The Sydney system category classification identified 56.9% of cases as malignant, while 26.1% were benign. The final surgical specimen diagnosis revealed a higher percentage of malignant diagnoses, with the highest risk of malignancy (ROM) in malignant/category V. In conclusion, our study demonstrates that LN-FNAC offers high diagnostic accuracy for lymph node (LN) aspirates, with the Sydney approach potentially aiding risk stratification and achieving consistency in cytologic diagnosis, but further multi-centric research is needed.Keywords
All Related Versions
This publication has 23 references indexed in Scilit:
- Challenges and opportunities in lymph node FNA: Insights from the DELYCYUS studyCancer Cytopathology, 2023
- Real‐world experience with the Sydney System on 1458 cases of lymph node fine needle aspiration cytologyCytopathology, 2021
- Lymph node FNA cytology: Diagnostic performance and clinical implications of proposed diagnostic categoriesCancer Cytopathology, 2021
- Ultrasound-Guided Fine-Needle Aspiration of Superficial Lymphadenopathy Performed by Interventional Pathologists: The Applicability of the Sydney System from 2 Years of Experience and 363 CasesActa Cytologica, 2021
- Assessment of risk of malignancy by application of the proposed Sydney system for classification and reporting lymph node cytopathologyCancer Cytopathology, 2021
- A Proposal for the Performance, Classification, and Reporting of Lymph Node Fine-Needle Aspiration Cytopathology: The Sydney SystemActa Cytologica, 2020
- Announcement: The International System for Reporting Lymph Node CytopathologyActa Cytologica, 2020
- Fine needle aspiration cytology for lymph nodes: a three-year studyBritish Journal of Biomedical Science, 2016
- Reliability of fine needle aspiration cytology (FNAC) as a diagnostic tool in cases of cervical lymphadenopathyJournal of the Egyptian National Cancer Institute, 2011
- The diagnostic value of fine needle aspiration cytology (FNAC) in the assessment of palpable supraclavicular lymph nodes: a study of 218 casesCytopathology, 2003